Dramatic response to alectinib in a patient of ALK-rearranged lung cancer with poor performance status
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s13104-016-1983-9
Published Online: 2016-03-17
Published Print: 2016-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Tanaka, Hisashi
Taima, Kageaki
Morimoto, Takeshi
Nakamura, Kunihiko
Tanaka, Yoshihito
Itoga, Masamichi
Takanashi, Shingo
Okumura, Ken